Related Experiment Video
Updated: Mar 14, 2026
06:22
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
1.6K
Combating Combination of Hypertension and Diabetes in Different Rat Models
Talma Rosenthal1, Firas Younis2, Ariela Alter3
1Department of Physiology and Pharmacology, Sackler School of Medicine, Tel Aviv University, Israel. rtalma@post.tau.ac.il.
Pharmaceuticals (Basel, Switzerland)
|October 8, 2016
Summary
Rat models illuminate hypertension and diabetes co-existence, a potent cardiovascular disease risk. Treatments manage key factors but don't prevent renal issues, highlighting the need for clinical translation of mechanisms like oxidative stress.
Area of Science:
- Cardiovascular Physiology
- Endocrinology
- Pharmacology
Background:
- Hypertension and diabetes mellitus are major cardiovascular disease (CVD) risk factors.
- Their co-existence significantly potentiates CVD risk.
- Understanding these combined pathologies is crucial for effective treatment strategies.
Approach:
- Review of five key rat experimental models: Zucker, Goto-Kakizaki, SHROB, SHR/NDmcr-cp, and Cohen Rosenthal diabetic hypertensive (CRDH) rats.
- Detailed examination of pharmacological (ACE inhibitors, ARBs, CCBs) and non-pharmacological interventions.
- Analysis of mechanisms including hypertension, hyperglycemia, hyperinsulinemia, and hyperlipidemia.
Key Points:
- Classical factors in combined hypertension and diabetes are treatable, but renal complications persist.
- Mechanisms like hypoxia, oxidative stress, and advanced glycation require further clinical translation.
- Identification of novel target molecules for integrated treatment modalities is ongoing.
Conclusions:
- Rat models provide valuable insights into the complex interplay of hypertension and diabetes.
- Current treatments show efficacy in managing contributing factors but not fully preventing renal damage.
- Bridging the gap between animal study findings and human clinical application remains a significant challenge.
